CAS: 1003-32-3; Thiazole-5-Carboxyaldehyde

该化合物是一个有机化合物,其特征为硫化物环结构,即五人组成的含有硫磺和氮原子的环环环,该化合物的特点是与硫化物环中的氮相邻的碳相连的碱性功能组(CHO),有助于其反应和有机合成中的潜在应用;它一般是无色的,可粉黄的液体或固体,视其纯度和形式而定. 5-Thiazolecarboxalthyde在合成各种药品和农用化学品以及染料和其他有机化合物方面的作用而闻名.

结构式图片

相似化合物

38585-74-9 14527-41-4 14527-44-7

欧盟法规

ECHA物质C&L通报

上下游产品

CAS号139669-95-7 2,4-二溴噻唑-5-甲醛 | CAS号92972-48-0 2,4-二氯噻唑-5-甲醛 | CAS号4394-85-8 N-甲酰吗啉 | CAS号116045-56-8 2-(trimethylsil... | CAS号38585-74-9 5-羟甲基噻唑 | CAS号38585-74-9 5-羟甲基噻唑 | CAS号238749-53-6 4H-吡咯并[2.3-d][1...

合成工艺路线路线简述

    2-(三甲基甲硅烷基)噻唑-5-甲醛置于盐酸体系中,用 四氢呋喃 用作溶剂,化学反应 2.0H,反应生成5-噻唑甲醛
    参考文献:A New Convenient Preparation Of 2-,4-,And 5-Thiazolecarboxaldehydes And Their Conversion Into The Corresponding Carbonitrilen-Oxides: Synthesis Of 3-Thiazolylisoxazoles And 3-Thiazolylisoxazolines
    标题:A New Convenient Preparation Of 2-,4-,And 5-Thiazolecarboxaldehydes And Their Conversion Into The Corresponding Carbonitrilen-Oxides: Synthesis Of 3-Thiazolylisoxazoles And 3-Thiazolylisoxazolines
    摘要:标题醛类化合物通过淬灭2-锂噻唑,4-锂-和5-锂-2-三甲基硅基噻唑与n-甲酰吗啉来制备,产率较高.在后两种情况下,随后进行脱硅化处理.这些醛类化合物通过其肟和羟肟酰氯转化为氰化物,与烯烃和乙炔二极亲电试剂反应,以中等至非常好产率得到3-噻唑基异恶唑啉和3-噻唑基异恶唑.
    Doi:10.1055/s-1987-28146

    专利信息


    专利号:WO-9746543-A1
    优先权日:1996-05-31
    标题:Acetyl derivatives of thiazoles and analogues
    发明人:PYNE STEPHEN GEOFFREY; UNG ALISON THAVARY
    权利人:UNIV WOLLONGONG; PYNE STEPHEN GEOFFREY; UNG ALISON THAVARY
    摘要:The present invention is directed to compounds useful in the treatment of autoimmune diseases and inflammatory diseases of general formula (I) wherein R1 is alkyl, alkenyl or alkynyl having from 1 to 6 carbons, phenyl, benzyl or phenethyl; R2 is H, C1 to C5 alkyl which can optionally be partially hydroxylated or the group (a) wherein n is from 0 to 4; and X, Y and Z are independently CH, N, NH, O or S, or a pharmaceutically acceptable ester or acid addition salt thereof, or a stereoisomer or a geometric isomer thereof, with the proviso that at least one of X, Y or Z is CH, that one and only one of X, Y and Z is NH, O or S and further that when Y is N or NH then Z is not N or NH. The present invention is also concerned with processes for the synthesis of the compounds and with methods of use of the compounds.

    专利号:US-2024002405-A1
    优先权日:2022-06-01
    标题 :Antimicrobial compounds, synthesis methods, and uses thereof
    发明人:VERMA RAJNI; DONAVALLI KRISHNA MOHAN; ZAID GENE H
    权利人:ANKH LIFE SCIENCES LTD
    摘要:Fused tricyclic compounds and novel methods of synthesizing, using, and/or administering the same. Methods of inhibiting microbial activity and/or treating a microbial infection with fused tricyclic compounds, bicyclic compounds, and other polycyclic compounds. The treatment of subjects suffering from a microbial infection comprises the step of administering to the subject one or more fused tricyclic compounds, bicyclic compounds, and other polycyclic compounds or a composition comprising one or more fused tricyclic compounds, bicyclic compounds, and other polycyclic compounds.

    专利号:US-6852711-B2
    优先权日:1998-09-11
    标题:HIV protease inhibitors
    发明人:BOYER JR FREDERICK EARL; DOMAGALA JOHN MICHAEL; ELLSWORTH EDMUND LEE; GAJDA CHRISTOPHER ANDREW; HAGEN SUSAN ELIZABETH; LOVDAHL MICHAEL JAMES; LUNNEY ELIZABETH ANN; MARKOSKI LARRY JAMES; PRASAD JOSYULA VENKATA NAGENDR; TAIT BRADLEY DEAN
    权利人:AGOURON PHARMA
    摘要:The present invention relates to novel dihydropyrones with tethered heterocycles having improved pharmacologic properties which potently inhibit the HIV aspartyl protease blocking HIV infectivity. The dihydropyrones are useful in the development of therapies for the treatment of viral infections and diseases, including AIDS. The present invention is also directed to methods of synthesis of the dihydropyrones and intermediates useful in the preparation of the final compounds.

    专利号:WO-2008153870-A1
    优先权日:2007-06-07
    标题 :Synthesis of substituted-3-aminopyrazoles

    专利号:US-2012029204-A1
    优先权日:2007-06-07
    标 题 :Synthesis of substituted-3-aminopyrazoles

    专利号:CN-117603202-A
    优先权日:2023-11-16
    标 题:Synthesis method of pyrrolidine derivative substituted by 2-nitrogen heterocycle
    南通嘉星泰生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.jxtbio.com
    企业联系电话:18795782766;13773776703👤
    📞南通嘉星泰生物科技有限公司 ⚠️参考联系方式
    联系人:蔡先生
    电话:18795782766;13773776703

    传真:0513-87503981
    邮箱:297962169@qq.com
    通信地址: 江苏省如皋市石庄镇张扬园村十组42号
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省如皋市石庄镇张扬园村十组42号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    参考文献:10.1007/978-94-011-3848-2_1
    摘要:Kikelj, D.; Urleb, U., Science of Synthesis, (2002) 11, 763.
    摘要:Kikelj, D.; Urleb, U., Science of Synthesis, (2002) 11, 786.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知